These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21910157)

  • 1. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
    Martín-Guerrero I; Enjuanes A; Richter J; Ammerpohl O; Colomer D; Ardanaz M; Marco F; Salas A; Campo E; Siebert R; García-Orad A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):887-95. PubMed ID: 21910157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].
    Xu W; Li JY; Li L; Wu YJ; Yu H; Shen QD; Qiu HX
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):450-3. PubMed ID: 19035176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
    Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
    Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
    Joshi AD; Dickinson JD; Hegde GV; Sanger WG; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Cancer Genet Cytogenet; 2007 Jan; 172(2):120-6. PubMed ID: 17213020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine.
    Cejkova S; Rocnova L; Potesil D; Smardova J; Novakova V; Chumchalova J; Zezulkova D; Borsky M; Doubek M; Brychtova Y; Pospisilova S; Klabusay M; Mayer J; Trbusek M
    Eur J Haematol; 2009 Feb; 82(2):133-42. PubMed ID: 19018867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
    Zhang L; Yang M; Bi N; Fang M; Sun T; Ji W; Tan W; Zhao L; Yu D; Lin D; Wang L
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1360-8. PubMed ID: 20171797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene atm and chronic lymphocytic leukemia - review].
    Zhu DX; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
    Bredemeyer AL; Sharma GG; Huang CY; Helmink BA; Walker LM; Khor KC; Nuskey B; Sullivan KE; Pandita TK; Bassing CH; Sleckman BP
    Nature; 2006 Jul; 442(7101):466-70. PubMed ID: 16799570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM polymorphisms and risk of lung cancer among never smokers.
    Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen YM; Huang MS; Chen HL; Yang PC; Chen CJ; Hsiung CA
    Lung Cancer; 2010 Aug; 69(2):148-54. PubMed ID: 20004998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
    Lu Y; Huang Q
    Leuk Res; 2009 Aug; 33(8):e124-6. PubMed ID: 19269030
    [No Abstract]   [Full Text] [Related]  

  • 15. ATM mutations in B-cell chronic lymphocytic leukemia.
    Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
    Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
    Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
    Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
    Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
    Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
    Joshi AD; Hegde GV; Dickinson JD; Mittal AK; Lynch JC; Eudy JD; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5295-304. PubMed ID: 17875758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.